New research demonstrates the importance of negative results, says Torsten Rackoll […]
Latest articles
Gauging the validity of cancer drug trials: a call for collaboration
In a new research paper published in The BMJ, we examine the evidence base supporting the European Medicines Agency (EMA)’s approval of cancer drugs. Of 32 new cancer drugs approved […]
Alex Nowbar’s journal review—18 September 2019
Alex Nowbar reviews the latest research from the top medical journals […]
R.L Burke: Bedside Betsy (2100: A Health Odyssey short stories)
Where’s little Ava?” I asked. Strange – it seemed I should know the answer to that. Hadn’t she just been in my arms, nursing? I felt light-headed, but it had […]
Anna Howells: There is only science eventually
Anna Howells introduces 2100: A Health Odyssey, the science-fiction writing competition breathing life into the discussion about healthcare, past, present and future. Return to BMJ Opinion over the next week […]
Hussain Jafri: Fighting for patient safety and advocacy in Pakistan
Partnership is key to bringing patient centred healthcare to Pakistan and the world, says Hussain Jafri […]
Regina Mariam Namata Kamoga: In the past the views of patients were not respected
The WHO initiative for patient advocacy is helping local activists to improve patient safety in Uganda and beyond, says Regina Mariam Namata Kamoga […]
Amandip Sidhu: Doctors are dying from stigma
In November 2018 my brother killed himself. He was 48 years old. He was a hard working consultant cardiologist whose motivation in life was to serve his patients. His death […]
Clare Gerada: Awareness of suicide is important, but more vital are formalised measures to prevent it
While suicide is rare, it happens often enough that many doctors have been personally affected by a colleague, friend or family member taking their own lives. Estimates for the numbers […]
Richard Smith: The “NCD crowd” vent their frustrations but identify some ways forward
“Frustrated” was the word used several times to describe the mood of people interested in combatting NCD (non-communicable disease) at a meeting at Chatham House last week. Progress is slow: […]
